Revamped R&E Tax Strategies Under the OBBBA

Research and Experimental (R&E) expenses are crucial for driving innovation across various sectors. Historically, their favorable tax treatment has fueled business innovation by enabling deductions that lower taxable income, promoting growth and development.

The One Big Beautiful Bill Act (OBBBA), effective from July 4, 2025, reinstates the immediate expensing of domestic Research and Experimental costs, reversing the 2017 Tax Cuts and Jobs Act's (TCJA) capitalization requirement. This change, codified in the new Internal Revenue Code (IRC) Section 174A, reestablishes a vital incentive for U.S.-based innovation, albeit maintaining stringent capitalization rules for international R&E efforts.

Image 1

Defining R&E Costs

Also known as R&D costs, R&E expenses generally encompass expenditures related to product development or enhancement, including software development. These costs typically include:

  • Personnel wages directly involved in research.

  • Materials and supplies utilized in research projects.

  • Fees for outsourced research services.

  • Overhead expenses related to research facilities, such as rent, utilities, and maintenance.

Image 3

The IRS's broad definition incentivizes a wide array of innovative pursuits.

A Brief History of R&E Expensing

Prior to the TCJA's changes in 2022, businesses could either fully deduct R&E costs or capitalize and amortize them over a minimum of 60 months. This flexibility extended significant cash flow benefits, especially for R&D-intensive enterprises.

Starting in 2022, the TCJA mandated the capitalization and amortization of R&E expenses over five years for domestic activities and 15 years for international projects. This shift imposed substantial tax burdens, particularly on startups, which faced delayed recognition of these tax benefits.

Image 2

Impact of the OBBBA

Effective for tax years beginning after December 31, 2024, the OBBBA fundamentally reshapes domestic R&E expensing:

  • Domestic R&E Expenditures: These can be fully deducted in the year incurred, aligning with pre-2022 practices and encouraging U.S.-based research. Businesses retain the option of amortizing these costs over 60 months if desired.

  • Foreign R&E Expenditures: The existing 15-year amortization requirement persists for international projects, disallowing immediate expense recovery for foreign R&E, which may drive multinationals to reassess their research venues to optimize tax outcomes.

Options for Accelerating Previously Amortized Expenses

The OBBBA offers transitional relief for R&E costs capitalized between 2022-2024:

  • Option 1: Complete Expensing in 2025: Deduct the full balance of unamortized domestic costs at the start of the 2025 tax year.

  • Option 2: Two-Year Expensing: Spread the remaining balance over two years, claiming 50% in 2025 and 50% in 2026.

  • Option 3: Continue the Original Amortization: Maintain the original five-year amortization plan.

  • Small Business Special Provision: Eligible small businesses, generally those with average gross receipts under $31 million, have an option for retroactive expensing via amended returns for 2022-2024, potentially reclaiming taxes paid under previous rules. This must be filed by July 4, 2026, with adjustments to the R&D credit necessary.

Interaction with Other Tax Provisions

The renewed R&E expensing rules interplay significantly with other tax code components, such as net operating losses (NOL), bonus depreciation, and international tax regulations. Businesses should strategically consider these together to maximize tax benefits for 2025 and beyond. Immediate deduction opportunities can notably reduce tax liabilities, facilitating advantageous financial planning.

Changes in Accounting These transitional provisions qualify as an automatic accounting method change, easing compliance burdens. The ability to "catch-up" on deductions presents a valuable cash flow opportunity, providing immediate alleviation from former capitalization directives. The IRS offers Rev Proc 2025-28 guidance on seamlessly adopting these changes by attached statement instead of through Form 3115, "Application for Change in Accounting Method."

Reach out to our office for detailed modeling of these options to discover the optimal strategy for your scenario, especially regarding their interaction with Net Operating Loss (NOL) and business interest expense limitations.

Share this article...

Want tax & accounting tips and insights?

Sign up for our newsletter.

I confirm this is a service inquiry and not an advertising message or solicitation. By clicking “Submit”, I acknowledge and agree to the creation of an account and to the and .